Healthy
Showing NaN - NaN of 45
Healthy, Premenstrual Dysphoric Disorder, Premenstrual Syndrome Trial in Glendale (Mixhers HERTIME, Placebo)
Active, not recruiting
- Healthy
- +2 more
- Mixhers HERTIME
- Placebo
-
Glendale, ArizonaMidwestern University
Nov 15, 2023
Healthy Trial in Glendale (Y-2 Sublingual Tablet, Placebo)
Not yet recruiting
- Healthy
- Y-2 Sublingual Tablet
- Placebo
-
Glendale, CaliforniaParexel International Los Angeles Early Phase Clinical Unit
Jul 10, 2023
Healthy Trial in Glendale (ALN-PNP, Placebo (PB))
Recruiting
- Healthy
- ALN-PNP
- Placebo (PB)
-
Glendale, CaliforniaCalifornia Clinical Trials Medical Group
Jan 31, 2023
Healthy, Alzheimer Trial in United States (Lu AF87908, Placebo)
Recruiting
- Healthy
- Alzheimer Disease
- Lu AF87908
- Placebo
-
Glendale, California
- +5 more
Dec 13, 2022
Healthy, Dermatitis, Atopic Trial in Glendale (LY3844583, Placebo)
Recruiting
- Healthy
- Dermatitis, Atopic
- LY3844583
- Placebo
-
Glendale, CaliforniaParexel Early Phase Unit at Glendale
Aug 17, 2022
Healthy Trial in Glendale (Rodatristat Ethyl 300 mg BID, Rodatristat Ethyl 600 mg BID, Placebo)
Completed
- Healthy
- Rodatristat Ethyl 300 mg BID
- +2 more
-
Glendale, CaliforniaCalifornia Clinical Trials Medical Group (CCTMG)
Jul 11, 2022
Healthy Trial in Glendale (Setmelanotide, Moxifloxacin, Oral Placebo)
Completed
- Healthy
- Setmelanotide
- +3 more
-
Glendale, CaliforniaParexel Early Phase Clinical Unit (Los Angeles)
Jun 15, 2022
Healthy, Parkinson Disease Trial in United States (Lu AF82422, Placebo)
Completed
- Healthy
- Parkinson Disease
- Lu AF82422
- Placebo
-
Glendale, California
- +3 more
Oct 5, 2021
Healthy Trial in Glendale (TAK-831 Tablet T2, Placebo, TAK-831 Suspension)
Completed
- Healthy
- TAK-831 Tablet T2
- +2 more
-
Glendale, CaliforniaCalifornia Clinical Trials Medical Group/PAREXEL
Jun 9, 2021
Healthy Trial in Glendale (LY3323795, Itraconazole, Placebo)
Completed
- Healthy
- LY3323795
- +2 more
-
Glendale, CaliforniaCalifornia Clinical Trials Medical Group
Apr 9, 2020
Submental Fat, Healthy Trial in Canada, United States (ATX-101, Placebo)
Healthy Trial in Glendale (Tucatinib)
Completed
- Healthy
-
Glendale, CaliforniaPAREXEL International, Early Phase Clinical Unit - Los Angeles
Sep 3, 2019
Healthy Trial in Glendale (LY3361237 - SC, LY3361237 - IV, Placebo - SC)
Completed
- Healthy
- LY3361237 - SC
- +3 more
-
Glendale, CaliforniaCalifornia Clinical Trials Medical Group
Sep 2, 2019
Healthy Trial in Glendale (LY3375880 IV, LY3375880 SC, Placebo IV)
Completed
- Healthy
- LY3375880 IV
- +3 more
-
Glendale, CaliforniaParexel Early Phase Unit at Glendale
Dec 7, 2018
Healthy Trial in Glendale (tofacitinib modified-release (MR) formulation)
Completed
- Healthy
- tofacitinib modified-release (MR) formulation
-
Glendale, CaliforniaGlendale Adventist Medical Center
Nov 28, 2018
Healthy Trial in Arcadia, Glendale (PF-06412562 3mg BID, PF-06412562 15mg BID, Placebo)
Terminated
- Healthy
- PF-06412562 3mg BID
- +2 more
-
Arcadia, California
- +2 more
Aug 14, 2017
Healthy Trial in Glendale, Baltimore (LY3041658 (SC), LY3041658 (IV), Placebo)
Completed
- Healthy
- LY3041658 (SC)
- +2 more
-
Glendale, California
- +1 more
Feb 14, 2017
Healthy Trial in Glendale (Placebo (SC), LY3200327 (SC), LY3200327 (IV))
Completed
- Healthy
- Placebo (SC)
- +3 more
-
Glendale, CaliforniaParexel International/ California Clinical Trials
Sep 9, 2016
Healthy Trial in Glendale (LY3154207, Placebo, Modafinil)
Completed
- Healthy
- LY3154207
- +2 more
-
Glendale, CaliforniaParexel Early Phase Unit at Glendale
Apr 4, 2016
Healthy Trial in Glendale (T89 Group A, Placebo Group A, Placebo Group B)
Completed
- Healthy
- T89 Group A
- +5 more
-
Glendale, CaliforniaCalifornia Clinical Trial Medical Group
Nov 16, 2014